- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03482076
Iron Deficiency Anemia in Childern With Liver Cirrhosis (IDA)
March 23, 2018 updated by: Bahaa Khaled Mohamed Mohamed, Assiut University
Prevelance of Iron Deficiency Anemia in Liver Cirrhosis in Childern
Iron deficiency anemia is a common complication of liver cirrhosis in childern and may affects there life this study to improve the outcome of these patients
Study Overview
Status
Unknown
Intervention / Treatment
Detailed Description
Patients with cirrhosis are at risk of developing both IDA and anemia of chronic disease concomitantly, and there adverse effects can deteriorate general condition and affect of quality of life in these patients .Also because it is easier to correct IDA than anemia of chronic disease, so this study of the prevalence of IDA helping us in the diagnosis and treatment of IDA and can reduce the need for other diagnostic tests and improve the quality of life in patients with cirrhosis .
Study Type
Interventional
Enrollment (Anticipated)
50
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Bahaa Khaled Mohamed
- Phone Number: 002 +201002755105
- Email: drbahaakhaled@gmail.com
Study Contact Backup
- Name: Nagla Hassan Ibrahim
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
1 month to 18 years (Child, Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- all childern with liver cirrhosis in GIT and hepatology unit
Exclusion Criteria:
- Neonates less than one month
- childern with other liver diseases
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: transferrin receptor concentration
Prevelance of iron deficiency in this patients
|
Sandwich radio-imunoassay
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Prevelance of IDA in liver cirrhosis
Time Frame: two years
|
To evaluate results
|
two years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
March 1, 2019
Primary Completion (Anticipated)
March 1, 2020
Study Completion (Anticipated)
June 1, 2020
Study Registration Dates
First Submitted
March 23, 2018
First Submitted That Met QC Criteria
March 23, 2018
First Posted (Actual)
March 29, 2018
Study Record Updates
Last Update Posted (Actual)
March 29, 2018
Last Update Submitted That Met QC Criteria
March 23, 2018
Last Verified
March 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- DBK
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Liver Cirrhosis
-
Postgraduate Institute of Medical Education and...Society for the Study of Liver Diseases, Chandigarh ( India )UnknownDecompensated Cirrhosis of LiverIndia
-
The Second Affiliated Hospital of Chongqing Medical...RecruitingFibrosis, Liver | Cirrhosis, LiverChina
-
SUUMC Central Military Hospital Dr Carol DavilaRecruiting
-
The Cleveland ClinicRecruiting
-
The Cleveland ClinicRecruitingCirrhosis, LiverUnited States
-
University of PittsburghNational Institute on Drug Abuse (NIDA)CompletedCirrhosis, LiverUnited States
-
Beth Israel Deaconess Medical CenterAmerican Association for the Study of Liver Diseases FoundationCompleted
-
Asian Institute of Gastroenterology, IndiaCompletedCirrhosis, LiverIndia
-
Sherief Abd-ElsalamUnknown
Clinical Trials on transferrin receptor concentration
-
Xenova BiomedixUnknownBrain and Central Nervous System TumorsUnited States
-
Topokine Therapeutics, Inc.Completed
-
NestléCompletedStroke | DysphagiaBelgium, France
-
Yale UniversityNational Institute on Drug Abuse (NIDA)Completed
-
Shanxi Provincial Maternity and Children's HospitalUnknown
-
Lille Catholic UniversityCompletedTransferrin Saturation Coefficient and Ferritinemia in Diagnosis of Iron Deficiency (CarenceMartial)Iron-deficiency | Internal Medicine | Transferrin | FerritinemiaFrance
-
ALK-Abelló A/STerminated
-
Qilu Pharmaceutical Co., Ltd.Recruiting
-
MeiraGTx, LLCRecruitingGrade 2 and 3 Late Xerostomia Caused by Radiotherapy for Cancers of the Upper Aerodigestive Tract, Excluding the Parotid GlandsUnited States, Canada
-
Topokine Therapeutics, Inc.CompletedLipodystrophy | Lipoatrophy | Nasolabial FoldsUnited States